Latest / Markets & Money News Today | 2 Min News | THE DAILY NOW!
Gene Therapy Advancements Blocked by Access | Markets & Money News
Recent FDA approvals of the gene therapies Casgevy and Lyfgenia offer new prospects for those suffering from sickle cell disease, a condition affecting around 100,000 people in the U.S. However, access to these treatments remains a significant challenge, as patients encounter varied healthcare costs and availability. Despite high efficacy rates, the uptake of these therapies is slow, highlighting the need for improved support systems. Efforts are underway to enhance access, but overcoming
www.TheDailyNewsNow.com
This is an automated, high-level news summary based on public reporting and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.